In the battle against antibiotic resistance, some scientists are trying a new approach: re-sensitising bacteria to drugs they no longer respond to so that existing antibiotics can hit their target once more.
Oct 21, 2019
0
14
Resistance to commonly-used antibiotics for treating harmful bacteria related to a variety of stomach conditions has more than doubled in 20 years, new research presented today at UEG Week Barcelona 2019 has shown.
Oct 21, 2019
0
4
New weapons are needed to fight drug-resistant bacteria, one of the biggest threats to global health. By working on new antibiotics or finding ways to revive existing ones in our medical arsenal, scientists aim to avoid a ...
Oct 15, 2019
0
4
People with type 2 diabetes often suffer from poorly-healing infected wounds on their feet. Using existing methods, however, it takes two days to grow a bacterial culture used to identify the pathogens infecting the wound ...
Oct 10, 2019
0
0
U.S. infections from three sexually transmitted diseases have risen for the fifth consecutive year.
Oct 8, 2019
0
3
The health care market is failing to support new antibiotics used to treat some of the world's most dangerous, drug-resistant "superbugs," according to a new analysis by University of Pittsburgh School of Medicine infectious ...
Oct 7, 2019
0
5
Wound inflammation that results in impaired wound healing can have serious consequences for patients. Researchers from Charité - Universitätsmedizin Berlin have discovered a new defensive mechanism that enables skin to ...
Oct 7, 2019
0
98
A new test to determine whether antibiotics will be effective against certain bacterial infections is helping physicians make faster and better prescription treatment choices.
Oct 3, 2019
0
3
People with type 2 diabetes often suffer from poorly-healing infected wounds on their feet. Using existing methods, however, it takes two days to grow a bacterial culture used to identify the pathogens infecting the wound ...
Oct 1, 2019
0
3
Infections are a leading cause of death worldwide. But widespread resistance to almost all available antibacterials is a reality in low and middle-income countries. It is thought to be most acute in sub-Saharan Africa.
Oct 1, 2019
0
2
